![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1562047 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKS2 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CKS2 mRNA | CTD | PMID:22079256 | (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of CKS2 mRNA | CTD | PMID:16949557 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1557386 | 6480464 | Ethinyl Estradiol results in increased expression of CKS2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1562047 | 6480464 | Ethinyl Estradiol affects the expression of CKS2 mRNA | CTD | PMID:17351261 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1557386 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1557386 | 6480464 | Ethinyl Estradiol affects the expression of CKS2 mRNA | CTD | PMID:17555576 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CKS2 mRNA | CTD | PMID:19167446 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1557386 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1557386 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1557386 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS2 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CKS2 mRNA | CTD | PMID:17942748, PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1557386 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CKS2 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557386 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CKS2 mRNA | CTD | PMID:21570461 | 2,3-dimethoxynaphthalene-1,4-dione | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:17547211, PMID:19031421 | 2-hydroxypropanoic acid | affects expression | EXP | | 6480464 | Lactic Acid affects the expression of CKS2 mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CKS2 mRNA | CTD | PMID:21179406 | 3-methylcholanthrene | increases expression | ISO | RGD:1557386 | 6480464 | Methylcholanthrene results in increased expression of CKS2 mRNA | CTD | PMID:20713471 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1557386 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of CKS2 mRNA | CTD | PMID:18648102 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1557386 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CKS2 mRNA | CTD | PMID:19191707 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1557386 | 6480464 | Fenretinide results in increased expression of CKS2 mRNA | CTD | PMID:28973697 | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CKS2 mRNA | CTD | PMID:17374387 | 5-fluorouracil | decreases expression | ISO | RGD:1557386 | 6480464 | Fluorouracil results in decreased expression of CKS2 mRNA | CTD | PMID:19272435 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1562047 | 6480464 | Propylthiouracil results in increased expression of CKS2 mRNA | CTD | PMID:24780913 | acrylamide | increases expression | ISO | RGD:1562047 | 6480464 | Acrylamide results in increased expression of CKS2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CKS2 protein | CTD | PMID:20106945 | aldehydo-D-glucose | increases expression | ISO | RGD:1557386 | 6480464 | Glucose results in increased expression of CKS2 mRNA | CTD | PMID:17178593 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CKS2 mRNA | CTD | PMID:21934132 | antimony(0) | increases expression | EXP | | 6480464 | Antimony results in increased expression of CKS2 mRNA | CTD | PMID:17547211 | aristolochic acid | decreases expression | ISO | RGD:1562047 | 6480464 | aristolochic acid I results in decreased expression of CKS2 mRNA | CTD | PMID:17483316 | arsenite(3-) | decreases expression | ISO | RGD:1557386 | 6480464 | arsenite results in decreased expression of CKS2 mRNA | CTD | PMID:18929588 | benzo[a]pyrene | increases expression | ISO | RGD:1557386 | 6480464 | Benzo(a)pyrene results in increased expression of CKS2 mRNA | CTD | PMID:20504355 | benzo[a]pyrene | decreases expression | ISO | RGD:1557386 | 6480464 | Benzo(a)pyrene results in decreased expression of CKS2 mRNA | CTD | PMID:21569818 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | bicalutamide | decreases expression | EXP | | 6480464 | bicalutamide results in decreased expression of CKS2 mRNA | CTD | PMID:15638997 | bis(2-chloroethyl) sulfide | decreases expression | EXP | | 6480464 | Mustard Gas results in decreased expression of CKS2 mRNA | CTD | PMID:25102026 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1557386 | 6480464 | Diethylhexyl Phthalate results in decreased expression of CKS2 mRNA | CTD | PMID:28085963 | bisphenol A | increases expression | ISO | RGD:1562047 | 6480464 | bisphenol A results in increased expression of CKS2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CKS2 mRNA | CTD | PMID:29275510 | buspirone | decreases expression | ISO | RGD:1562047 | 6480464 | Buspirone results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA | CTD | PMID:29432896 | cadmium dichloride | decreases expression | ISO | RGD:1562047 | 6480464 | Cadmium Chloride results in decreased expression of CKS2 mRNA | CTD | PMID:25993096 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CKS2 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKS2 mRNA | CTD | PMID:21592394 | carbon nanotube | increases expression | ISO | RGD:1557386 | 6480464 | Nanotubes, Carbon analog results in increased expression of CKS2 mRNA, Nanotubes, Carbon results in increased expression of CKS2 mRNA | CTD | PMID:25554681 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes, Carbon results in increased expression of CKS2 mRNA | CTD | PMID:28673683 | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of CKS2 mRNA | CTD | PMID:26352163 | chloropicrin | decreases expression | EXP | | 6480464 | chloropicrin results in decreased expression of CKS2 mRNA | CTD | PMID:28476498 | chloroprene | increases expression | ISO | RGD:1557386 | 6480464 | Chloroprene results in increased expression of CKS2 mRNA | CTD | PMID:23125180 | chlorpromazine | decreases expression | EXP | | 6480464 | Chlorpromazine analog results in decreased expression of CKS2 mRNA | CTD | PMID:15924885 | chromium(6+) | affects expression | ISO | RGD:1557386 | 6480464 | chromium hexavalent ion affects the expression of CKS2 mRNA | CTD | PMID:28472532 | ciguatoxin CTX1B | affects expression | ISO | RGD:1557386 | 6480464 | Ciguatoxins affects the expression of CKS2 mRNA | CTD | PMID:18353800 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CKS2 mRNA | CTD | PMID:27594783 | cisplatin | decreases expression | ISO | RGD:1557386 | 6480464 | Cisplatin results in decreased expression of CKS2 mRNA | CTD | PMID:25270620 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of CKS2 mRNA, Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] | CTD | PMID:21858171, PMID:27392435 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CKS2 mRNA | CTD | PMID:19376846 | copper atom | increases expression | ISO | RGD:1562047 | 6480464 | Copper results in increased expression of CKS2 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | RGD:1562047 | 6480464 | Copper results in increased expression of CKS2 mRNA | CTD | PMID:30556269 | copper(II) chloride | increases expression | EXP | | 6480464 | cupric chloride results in increased expression of CKS2 mRNA | CTD | PMID:17211630 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of CKS2 mRNA | CTD | PMID:19549813 | corticosterone | decreases expression | ISO | RGD:1562047 | 6480464 | Corticosterone results in decreased expression of CKS2 mRNA | CTD | PMID:15755911 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of CKS2 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of CKS2 mRNA | CTD | PMID:25351596 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CKS2 mRNA | CTD | PMID:20106945, PMID:27989131 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CKS2 mRNA | CTD | PMID:25562108 | cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of CKS2 mRNA | CTD | PMID:17374387 | D-glucose | increases expression | ISO | RGD:1557386 | 6480464 | Glucose results in increased expression of CKS2 mRNA | CTD | PMID:17178593 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of CKS2 gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | RGD:1557386 | 6480464 | Dibutyl Phthalate results in decreased expression of CKS2 mRNA | CTD | PMID:17361019, PMID:21266533 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CKS2 mRNA | CTD | PMID:15766595 | dioxygen | increases expression | ISO | RGD:1557386 | 6480464 | Oxygen deficiency results in increased expression of CKS2 mRNA | CTD | PMID:24205000 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of CKS2 mRNA | CTD | PMID:26516004 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | EXP | | 6480464 | Antimony Potassium Tartrate results in increased expression of CKS2 mRNA | CTD | PMID:17547211 | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of CKS2 mRNA | CTD | PMID:18175754 | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CKS2 mRNA | CTD | PMID:19244175 | endosulfan | decreases expression | ISO | RGD:1562047 | 6480464 | Endosulfan results in decreased expression of CKS2 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA | CTD | PMID:19167446 | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA | CTD | PMID:29432896 | flutamide | increases expression | ISO | RGD:1562047 | 6480464 | Flutamide results in increased expression of CKS2 mRNA | CTD | PMID:24793618 | fluvastatin | multiple interactions | EXP | | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA | CTD | PMID:16996129 | glucose | increases expression | ISO | RGD:1557386 | 6480464 | Glucose results in increased expression of CKS2 mRNA | CTD | PMID:17178593 | GW 4064 | multiple interactions | ISO | RGD:1557386 | 6480464 | GW 4064 promotes the reaction [NR1H4 protein binds to CKS2 gene] | CTD | PMID:20091679 | hydroxyurea | decreases expression | EXP | | 6480464 | Hydroxyurea results in decreased expression of CKS2 mRNA | CTD | PMID:17374387 | irinotecan | decreases expression | ISO | RGD:1562047 | 6480464 | Irinotecan results in decreased expression of CKS2 mRNA | CTD | PMID:20097248 | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA | CTD | PMID:29432896 | leflunomide | decreases expression | ISO | RGD:1562047 | 6480464 | leflunomide results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of CKS2 mRNA | CTD | PMID:28988120 | levofloxacin | decreases expression | ISO | RGD:1562047 | 6480464 | Levofloxacin results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | lipopolysaccharide | decreases expression | ISO | RGD:1557386 | 6480464 | Lipopolysaccharides results in decreased expression of CKS2 mRNA | CTD | PMID:12057914 | manganese atom | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of CKS2 mRNA | CTD | PMID:17175027 | manganese(0) | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of CKS2 mRNA | CTD | PMID:17175027 | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of CKS2 mRNA | CTD | PMID:17175027 | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of CKS2 mRNA | CTD | PMID:17547211 | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of CKS2 mRNA | CTD | PMID:17547211 | methapyrilene | increases expression | ISO | RGD:1562047 | 6480464 | Methapyrilene results in increased expression of CKS2 mRNA | CTD | PMID:30467583 | mitomycin C | decreases expression | ISO | RGD:1557386 | 6480464 | Mitomycin results in decreased expression of CKS2 mRNA | CTD | PMID:25270620 | N-nitrosodiethylamine | increases expression | ISO | RGD:1557386 | 6480464 | Diethylnitrosamine results in increased expression of CKS2 mRNA | CTD | PMID:17854601 | N-nitrosodiethylamine | increases expression | ISO | RGD:1562047 | 6480464 | Diethylnitrosamine results in increased expression of CKS2 mRNA | CTD | PMID:25242409 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:1557386 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKS2 mRNA] | CTD | PMID:17854601 | naphthalene | increases expression | ISO | RGD:1562047 | 6480464 | naphthalene analog results in increased expression of CKS2 mRNA | CTD | PMID:24976557 | nefazodone | decreases expression | ISO | RGD:1562047 | 6480464 | nefazodone results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of CKS2 mRNA | CTD | PMID:19031421, PMID:25583101 | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of CKS2 mRNA | CTD | PMID:17547211 | nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of CKS2 mRNA | CTD | PMID:16949557 | nimesulide | decreases expression | ISO | RGD:1562047 | 6480464 | nimesulide results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | ochratoxin A | increases expression | ISO | RGD:1562047 | 6480464 | ochratoxin A results in increased expression of CKS2 mRNA | CTD | PMID:18417182 | oxaliplatin | multiple interactions | ISO | RGD:1562047 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CKS2 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CKS2 mRNA | CTD | PMID:21420995 | phenobarbital | decreases expression | ISO | RGD:1557386 | 6480464 | Phenobarbital results in decreased expression of CKS2 mRNA | CTD | PMID:19363144 | PhIP | increases expression | ISO | RGD:1562047 | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of CKS2 mRNA | CTD | PMID:29877212 | phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CKS2 mRNA | CTD | PMID:19031421 | pinosylvin | decreases expression | EXP | | 6480464 | pinosylvin results in decreased expression of CKS2 mRNA | CTD | PMID:23333577 | pirinixic acid | increases expression | ISO | RGD:1562047 | 6480464 | pirinixic acid results in increased expression of CKS2 mRNA | CTD | PMID:22484513 | pirinixic acid | decreases expression | ISO | RGD:1557386 | 6480464 | pirinixic acid results in decreased expression of CKS2 mRNA | CTD | PMID:18445702, PMID:23811191 | piroxicam | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] | CTD | PMID:21858171 | piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of CKS2 mRNA | CTD | PMID:21858171 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CKS2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of CKS2 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:1557386 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CKS2 mRNA | CTD | PMID:28903501 | rac-lactic acid | affects expression | EXP | | 6480464 | Lactic Acid affects the expression of CKS2 mRNA | CTD | PMID:30851411 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CKS2 mRNA | CTD | PMID:15767336 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA | CTD | PMID:19167446 | retinyl acetate | increases expression | ISO | RGD:1557386 | 6480464 | retinol acetate results in increased expression of CKS2 mRNA | CTD | PMID:16772331 | rotenone | decreases expression | ISO | RGD:1562047 | 6480464 | Rotenone results in decreased expression of CKS2 mRNA | CTD | PMID:28374803 | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CKS2 mRNA | CTD | PMID:19244175 | serpentine asbestos | increases expression | ISO | RGD:1557386 | 6480464 | Asbestos, Serpentine results in increased expression of CKS2 mRNA | CTD | PMID:16251409 | silicon dioxide | increases expression | ISO | RGD:1562047 | 6480464 | Silicon Dioxide results in increased expression of CKS2 mRNA | CTD | PMID:22431001 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of CKS2 mRNA | CTD | PMID:25351596 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CKS2 mRNA | CTD | PMID:25266719, PMID:29301061 | sodium fluoride | increases expression | ISO | RGD:1557386 | 6480464 | Sodium Fluoride results in increased expression of CKS2 protein | CTD | PMID:28918527 | Soman | increases expression | ISO | RGD:1562047 | 6480464 | Soman results in increased expression of CKS2 mRNA | CTD | PMID:19281266 | tamoxifen | affects expression | ISO | RGD:1557386 | 6480464 | Tamoxifen affects the expression of CKS2 mRNA | CTD | PMID:17555576 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CKS2 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKS2 mRNA | CTD | PMID:21592394 | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of CKS2 mRNA | CTD | PMID:17440010 | tetrachloroethene | increases expression | EXP | | 6480464 | Tetrachloroethylene results in increased expression of CKS2 mRNA | CTD | PMID:19031421 | tetrachloromethane | increases expression | ISO | RGD:1562047 | 6480464 | Carbon Tetrachloride results in increased expression of CKS2 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:1562047 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKS2 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | RGD:1562047 | 6480464 | Thioacetamide results in increased expression of CKS2 mRNA | CTD | PMID:23411599, PMID:25242409 | titanium dioxide | increases expression | ISO | RGD:1557386 | 6480464 | titanium dioxide results in increased expression of CKS2 mRNA | CTD | PMID:23557971 | titanium dioxide | increases expression | ISO | RGD:1562047 | 6480464 | titanium dioxide results in increased expression of CKS2 mRNA | CTD | PMID:30012374 | topotecan | decreases expression | ISO | RGD:1562047 | 6480464 | Topotecan results in decreased expression of CKS2 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | RGD:1562047 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CKS2 mRNA | CTD | PMID:25729387 | trans-pinosylvin | decreases expression | EXP | | 6480464 | pinosylvin results in decreased expression of CKS2 mRNA | CTD | PMID:23333577 | trimellitic anhydride | increases expression | ISO | RGD:1557386 | 6480464 | trimellitic anhydride results in increased expression of CKS2 mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CKS2 mRNA | CTD | PMID:19140230 | troglitazone | increases expression | ISO | RGD:1557386 | 6480464 | troglitazone results in increased expression of CKS2 mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | ISO | RGD:1562047 | 6480464 | trovafloxacin results in decreased expression of CKS2 mRNA | CTD | PMID:24136188 | tungsten | increases expression | ISO | RGD:1557386 | 6480464 | Tungsten results in increased expression of CKS2 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | RGD:1557386 | 6480464 | Urethane results in increased expression of CKS2 mRNA | CTD | PMID:16289808 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of CKS2 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CKS2 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CKS2 mRNA | CTD | PMID:25979313 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CKS2 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CKS2 mRNA | CTD | PMID:18593933 | zoledronic acid | multiple interactions | EXP | | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA | CTD | PMID:16996129 | |

Biological Process
Cellular Component
Molecular Function